Suppr超能文献

根据不同标准诊断的、行择期血管造影术的糖尿病和非糖尿病代谢综合征患者的冠状动脉粥样硬化严重程度。

The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography.

机构信息

Department of Endocrinology and Metabolic Diseases, Ufuk University, Dr. Ridvan Ege Hospital, Mevlana Bulvari, Ankara, Turkey.

出版信息

Acta Diabetol. 2011 Mar;48(1):21-7. doi: 10.1007/s00592-010-0211-7. Epub 2010 Aug 3.

Abstract

Our aim in this study was to evaluate the relationship between metabolic syndrome (MS) as defined by different criteria and the severity of coronary lesions in a sample of diabetic and non-diabetic patients undergoing elective coronary angiography. All patients had blood and urine tests, physical examinations were performed before angiography, and finally they were classified based on three criteria (World Health Organisation-WHO, Adult Treatment Panel-ATP III and International Diabetes Federation-IDF). Eighty-eight patients were diabetic, and 96 patients were non-diabetic. Among all patients, diabetics had significantly higher Gensini scores (P < 0.001). According to WHO criteria (P = 0.005) and IDF criteria (P = 0.015) metabolic syndrome patients had higher Gensini scores, but for ATP III criteria difference was not significant. When we evaluated diabetics and non-diabetics separately, non-diabetic patients with MS had significantly higher scores with WHO definition (P = 0.015) and mildly higher but not significant values with other MS criteria (P = 0.057 for both IDF and ATP III). Neither any one of MS components nor gender revealed significant relationship with coronary disease severity. In our study with a cohort of Turkish patients undergoing elective coronary angiography; we concluded that MS should be taken into consideration, especially in non-diabetic patients.

摘要

本研究旨在评估不同标准定义的代谢综合征(MS)与接受选择性冠状动脉造影的糖尿病和非糖尿病患者冠状动脉病变严重程度之间的关系。所有患者均进行了血液和尿液检查,在进行血管造影前进行了体格检查,最后根据三项标准(世界卫生组织[WHO]、美国成人治疗组第三次报告[ATP III]和国际糖尿病联合会[IDF])进行分类。88 名患者为糖尿病,96 名患者为非糖尿病。在所有患者中,糖尿病患者的 Gensini 评分明显更高(P<0.001)。根据 WHO 标准(P=0.005)和 IDF 标准(P=0.015),代谢综合征患者的 Gensini 评分更高,但根据 ATP III 标准,差异无统计学意义。当我们分别评估糖尿病和非糖尿病患者时,非糖尿病代谢综合征患者的 WHO 定义评分明显更高(P=0.015),而其他 MS 标准的评分略高,但无统计学意义(IDF 和 ATP III 均为 P=0.057)。MS 的任何一个组成部分或性别均与冠状动脉疾病严重程度无显著关系。在我们对接受选择性冠状动脉造影的土耳其患者的队列研究中;我们得出结论,MS 应引起重视,尤其是在非糖尿病患者中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验